The stars are aligning for BASF on a single Wednesday. April 30 will see the German chemical giant release first-quarter results, hold its annual general meeting, and put the fate of its agricultural division to a shareholder vote — a rare convergence of corporate events that will test both management’s strategy and the market’s patience.
The Currency Headwind and a Modest Outlook
The Q1 numbers, due at 7:00 a.m., are expected to reflect a familiar drag: a weak US dollar that could shave up to €200 million off operating earnings. That currency pressure, combined with persistently high energy costs in Europe and sluggish demand from the automotive and construction sectors, sets a cautious tone. For the full year 2026, BASF forecasts EBITDA before special items in a range of €6.2 billion to €7.0 billion. The midpoint of that guidance, €6.6 billion, sits below the consensus estimate of roughly €7.0 billion, underscoring the headwinds the company faces.
Yet the stock has been on a tear. At €54.32, BASF shares have gained more than 21% since the start of the year, climbing from around €45 to within striking distance of their 52-week high of €54.70. That rally, however, now confronts a stubborn resistance zone between €54 and €55 — a level where the stock has failed three times since 2023. The relative strength index sits at 23.6, indicating oversold territory, which could either signal a pullback or leave room for an upside surprise if the April 30 events deliver.
The Agrar Spin-Off: A Structural Pivot
The most consequential item on the AGM agenda is the proposed spin-off of Agricultural Solutions, the company’s crop chemicals and seeds business. Shareholders will vote on transferring the division into a standalone subsidiary, paving the way for a planned initial public offering on the Frankfurt Stock Exchange in 2027.
This is no minor unit. Agricultural Solutions generated €9.6 billion in revenue in 2025. Under the plan, BASF will retain a majority stake in the new European stock corporation. Dr. Livio Tedeschi is set to take over as chairman of the new management board on May 1. The IT separation is already underway: the transition to an independent ERP system is complete in North America, with the rest of the world expected to follow by early 2027.
A Coatings Cash Infusion
While the spin-off grabs headlines, a separate deal is quietly adding firepower. BASF has agreed to sell its Coatings business to private equity firm Carlyle and the Qatar Investment Authority at an enterprise value of €7.7 billion. BASF will retain a 40% stake, and the transaction, expected to close in the second quarter, will deliver €5.8 billion in pre-tax cash proceeds, pending regulatory approvals.
Should investors sell immediately? Or is it worth buying BASF?
That war chest opens up options: debt reduction, further share buybacks, or fresh investment. It also complements the company’s existing capital return program. BASF is in the midst of a €1.5 billion share buyback launched in November 2025 and slated to run through June 2026. By early March, it had already spent €789 million to repurchase 17.5 million shares. That program is part of a broader €4 billion buyback commitment through 2028.
Cost Savings Outperform, Dividend Holds Steady
On the cost front, BASF has been delivering more than promised. Annualized savings reached €1.7 billion by the end of 2025, exceeding the original target by €100 million. The company has since raised its goal to €2.3 billion by the end of 2026.
The board is recommending a dividend of €2.25 per share for approval at the AGM — a signal of reliability even as the earnings outlook remains subdued. The payout will be voted on alongside the spin-off, giving shareholders a direct say in both capital allocation and corporate structure.
Analyst Divergence and the Day Ahead
The range of analyst opinions reflects the uncertainty. Barclays maintains an “underweight” rating with a price target of €40, while Bernstein Research recently lifted its target from €53 to €61. Which camp proves right may hinge on whether the Q1 report shows that cost cuts and pricing power can offset the currency drag.
For BASF, April 30 is more than a busy day on the calendar. It is a moment when earnings, a strategic restructuring, and a major divestiture converge — and the market will be watching closely to see whether the pieces add up to a stronger whole.
Ad
BASF Stock: Buy or Sell?! New BASF Analysis from April 25 delivers the answer:
The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
BASF: Buy or sell? Read more here...
